Mesh nebulizers are now an important delivery system for the treatment of high-value drugs in diseases such as cystic fibrosis and pulmonary hypertension where alternate delivery systems such as metered dose inhalers (MDIs) and dry powder inhalers (DPIs) have not been popular due to the higher cost of developing these .